Potential Effects on the Health Care System — 1

Food and Drug Administration: Labeling of prescription drugs for patients. Fed. Regist. 40: 52075–52076, Nov. 7, 1975.

Food and Drug Administration: Contractor's final report: Survey of consumers' perceptions of patient package inserts for oral contraceptives. National Technical Information Service, Springfield, VA, Sept. 1975, Accession HPB248-739.

Vickey D. M. Fries J. F. : Take care of yourself: A consumer's guide to medical care. Addison-Wesley, Reading, Mass., 1976.

Barofsky I. : Compliance, adherence and the therapeutic alliance. Proceedings of the First International Congress of Patient Counselling, Excerpta Medica (in press).

Food and Drug Administration: Drugs for human use: Estrogens and other drugs, Fed. Regist. 41: 43108–43123, Sept. 29, 1976.

Sackett D. L. Haynes R. B. Gibson E. S. Hackett B. C. Taylor D. W. Roberts R. S. Johnson A. L. : Randomized clinical trial of strategies for improving medication compliance in primary hypertension. Lancet 1: 1205–1207, 1975.

Freedman B. : A moral theory of informed consent. Hastings Cent. Rep. 4: 32–39, 1975.

Another aspect of consent not discussed here is that it occur voluntarily. Freedman (7) discusses this issue as well.

Stetler C. J. : Letter to FDA Hearing Clerk, March 3, 1976.

Fleckenstein L. Joubert P. Lawrence R. Patsher B. Mazzullo J. Lasagna L. : Oral contraceptive patient information: A questionnaire study of attitudes, knowledge and preferred information sources. JAMA 235: 1331–1336, 1976.

Lusted L. : Decision-making studies in patient management, N. Engl. J. Med. 284: 416–424, 1971.

McNeil B. J. Adelstein S. J. : Primer on certain elements of medical decision making, N. Engl. J. Med. 293: 211–215, 1975.

Weinstein M. C. Stason W. S. : Hypertension: A policy perspective. Harvard Univ. Press, Cambridge, 1976.